Introduction {#Sec1}
============

Carbohydrate oxidases oxidize their substrates with excellent regio- and/or enantioselectivity, which makes these enzymes of considerable industrial value. This is nicely illustrated by their use in diagnostics (biosensors for blood sugar) and in the food and drink industry (sweeteners and flavors; van Hellemond et al. [@CR40]). Most carbohydrate oxidases belong to a distinct subgroup of sequence-related flavoproteins, namely the vanillyl-alcohol oxidase (VAO) family. Members of this family are characterized by a similar overall structure comprising a FAD binding domain and a substrate binding domain (Fraaije et al. [@CR13]; Leferink et al. [@CR25]). Recently, we identified a novel member of the VAO family in the proteome of *Streptomyces coelicolor* A3(2), called AldO (alditol oxidase). AldO is a soluble monomeric flavoprotein of 45.1 kDa in which the flavin cofactor is covalently linked to the polypeptide chain (Heuts et al. [@CR16]). The covalent anchoring of the FAD cofactor is an autocatalytic process and will only occur upon correct folding of the polypeptide chain. Therefore, the covalently incorporated FAD can be used as a folding reporter. AldO catalyzes the C1 oxidation of several polyols such as xylitol and sorbitol (Heuts et al. [@CR16]). The recent determination of its atomic structure at a resolution of 1.1 Å has revealed the structural features that determine the catalytic mechanism and substrate specificity of AldO (Forneris et al. [@CR12]).

AldO is industrially relevant and can be used in various applications. At present, biotechnological exploitation of this enzyme is restricted by costly and laborious purification steps. It is therefore desirable to eliminate the need for enzyme purification using a whole-cell biocatalyst system. The use of AldO in such a system, however, is limited by the accessibility of substrates. Several strategies have been presented for *Escherichia coli*-based whole-cell biocatalyst systems to increase the accessibility of substrates. These include transport of foreign proteins to the periplasm and/or display at the cell surface (Samuelson et al. [@CR32]; Mergulhao et al. [@CR29]).

Proteins that function outside the cytoplasm (secretory proteins) can be exported to the periplasm of *E. coli* by different pathways. The vast majority of secretory proteins are exported across the inner membrane in an unfolded state via the Sec-translocon, which works as a protein conducting channel (Driessen and Nouwen [@CR8]). Most secretory proteins are targeted to the Sec-translocon in a posttranslational fashion by the chaperone SecB in concert with the ATPase SecA, which drives protein translocation (Vrontou and Economou [@CR41]; Zhou and Xu [@CR45]). A subset of secretory proteins is targeted to the Sec-translocon in a co-translational fashion that involves the signal recognition particle (SRP) and its receptor FtsY (Luirink and Sinning [@CR27]). In contrast to the Sec-translocon, the Twin-arginine translocation (Tat) system is able to export folded and often cofactor-containing secretory proteins to the periplasm posttranslationally (Lee et al. [@CR24]).

Various systems have been described for display of foreign proteins on the surface of *E. coli*, including phage display and systems based on anchoring motifs derived from outer membrane proteins, lipoproteins, or auto-transporters (Samuelson et al. [@CR32]; Lee et al. [@CR23]). One such recently explored anchoring motif is derived from the ice-nucleation protein (INP) InaK from *Pseudomonas syringae*. This protein is attached to the cell surface by an glycosyl-phosphatidylinositol (GPI) anchor and comprises three structurally different domains: the non-repetitive N- and C-terminal domains and a repetitive central domain (Turner et al. [@CR39]; Graether and Jia [@CR15]). Both full-length INP and a truncated variant lacking the central domain are able to facilitate the surface display of foreign proteins, indicating that the non-repetitive domains are required for targeting and anchoring to the cell surface. Therefore, an INP derivative constituting the N- and C-terminal domains is used to display foreign proteins on the surface of *E. coli* (Jung et al. [@CR19]; Lee et al. [@CR22]; Shimazu et al. [@CR35]; Cho et al. [@CR6]; Kang et al. [@CR20]; Li et al. [@CR26]; Wu et al. [@CR43]; Yim et al. [@CR44]).

In the present study, we have developed a whole-cell AldO biocatalyst system by directing AldO to the periplasm or cell surface of *E. coli*. For the transport across the inner membrane, we have explored several export systems. For periplasmic transport, AldO was fused to endogenous *E. coli* Sec and Tat signal sequences. A truncated INP derivative was used for surface display of AldO. The export of these constructs was analyzed by cellular fractionation and immunoblotting. Additionally, cellular fractions were assayed for oxidase activity. The results show that Tat-exported AldO and INP-surface-displayed AldO are active. The Tat-based system was successfully employed in converting xylitol by whole cells, whereas the use of the INP-based system was most likely restricted by LPS in wild-type cells. It is anticipated that these whole-cell systems, cells decorated with the biocatalyst of interest, will be a valuable tool for further biological and industrial exploitation of AldO and other cofactor-containing enzymes.

Materials and methods {#Sec2}
=====================

Reagents, enzymes, and sera {#Sec3}
---------------------------

Restriction enzymes were from Roche Applied Science and New England Biolabs. Expand long template polymerase chain reaction (PCR) system and P*fu* DNA polymerase were from Roche Applied Science and Invitrogen. Enhanced chemiluminescence (ECL) Western blotting detection reagent was from Amersham Biosciences. Horseradish peroxidase was from Fluka. All other chemicals were supplied by Sigma and of analytical grade. Antiserum against AldO was raised in a rabbit against the purified native protein and was prepared by Innovagen (Lund, Sweden). OmpA and DsbA antisera were kind gifts of H.D. Bernstein and J. Beckwith, respectively. DnaK antiserum was kindly provided by A. Mogk. Antiserum against riboflavin was from Abcam.

Strains, plasmids, and growth conditions {#Sec4}
----------------------------------------

*E. coli* strains MC1061 (Casadaban and Cohen [@CR5]) and Top10 (Invitrogen) were used as routine hosts for all plasmid constructs. Strains MC1061 and MC4100 (Casadaban [@CR4]) were used for subcellular localization experiments and whole cell-based conversions of xylitol. The *waaC* null mutant JW3596-1 (GGSC no. 11805) has been described previously (Baba et al. [@CR1]) and was obtained from the *E. coli* genetic stock center. JW3596-1 was used for the whole cell-based conversion of xylitol.

The plasmids pBAD-AldO and pBAD-MBP-AldO have been described earlier (Heuts et al. [@CR16]). The different signal sequence chimeras were constructed as follows. For transport via the Tat pathway, the signal sequence of TorA and the first four amino acid residues of the mature protein were PCR-amplified from *E. coli* K-12 genomic DNA. The PCR product was cloned *Nde*I/*Eco*RI into pBAD-MBP-AldO, thereby replacing the N-terminal MBP tag and yielding pBAD-Tat-AldO. The plasmid pBAD-Sec-AldO, encoding an MalE signal sequence-AldO hybrid, was obtained in a similar fashion after PCR amplification of the MalE signal sequence using pMal-p2X (New England Biolabs) as template. SRP-AldO was obtained by PCR from pBAD-MBP-AldO as template and using a forward primer that included the codons for the DsbA signal sequence and the first two residues of the mature protein. The PCR product was cloned into pBAD (Invitrogen), yielding pBAD-SRP-AldO. For cell surface display of AldO, a truncated variant of the *inaK* gene comprising the N- and C-terminal domains was synthesized by Sloning BioTechnology (München, Germany) and subsequently cloned *Nde*I/*Eco*RI into vector pBAD-MBP-AldO, thereby replacing the N-terminal MBP tag and yielding pBAD-INP-AldO. Nucleotide sequences were verified by DNA sequencing. Primer sequences are available upon request.

Cultures were grown to saturation at 37°C overnight. The following day, overnight cultures were back-diluted 1:100 into fresh media containing 0.02% [l]{.smallcaps}-arabinose to induce the expression of AldO or its derivatives and grown for 48 h at 17°C. All strains were routinely grown in Luria--Bertani medium (per liter, 10 g tryptone, 5 g yeast extract, 5 g NaCl) under aerobic conditions unless indicated otherwise. Where appropriate, ampicillin (100 μg/ml) or kanamycin (5 μg/ml) were added to the culture medium.

Cell fractionations {#Sec5}
-------------------

Cells expressing AldO or its signal sequence derivatives were grown as described above. Fifteen to 20 OD~660~ units of cells were harvested and fractionated into a spheroplast and periplasmic fraction as described (Huber et al. [@CR17]). The cytoplasmic fraction was obtained as follows. After disruption of the spheroplasts by sonication and a brief clarifying spin, the clarified lysate was ultracentrifuged (100,000×*g* for 40 min at 4°C) and the supernatant was taken as the cytoplasmic fraction. Cells expressing INP-AldO were grown as described above. Seventy-five OD~660~ units of cells were harvested and disrupted by sonication. The soluble, total membrane, inner membrane, and outer membrane fractions were obtained as described (Filip et al. [@CR11]). In both fractionation procedures, proteins were precipitated by trichloroacetic acid and analyzed by sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting.

SDS-PAGE and immunoblotting {#Sec6}
---------------------------

Cellular fractions were normalized on the basis of the OD~660~, and samples of these fractions containing equal OD~660~ units were analyzed on standard 12% SDS-PAGE gels. Proteins were transferred to nitrocellulose membrane (Amersham Biosciences) using a semidry apparatus from Biorad. Immunodetection was performed using the primary antisera described above, a secondary horseradish-peroxidase-coupled antiserum (Rockland), and the ECL system from Amersham Biosciences (according to the instructions of the manufacturer). Proteins were visualized using the Fujifilm LAS-3000 imaging system.

Analytical methods {#Sec7}
------------------

The oxidase activity of cellular fractions and whole cells expressing Tat-AldO or INP-AldO was determined by coupling the production of H~2~O~2~ by AldO or its derivatives to a horseradish-peroxidase-mediated oxidation of 4-aminoantipyrine and 3,5-di-chloro-2-hydroxybenzenesulfonic acid. The resulting pink adduct can be detected spectrophotometrically at 515 nm (*ɛ* ~515~ = 26 mM^−1^ cm^−1^; Federico et al. [@CR9]). For the detection of oxidase activity, phosphate-buffered saline (pH 7.4) was used as assay buffer containing 0.1 mM 4-aminoantipyrine, 1 mM 3,5-di-chloro-2-hydroxybenzenesulfonic acid, 3 U horseradish peroxidase, 5 mM xylitol, 0.01 OD~660~ units of cells (expressing Tat-AldO or INP-AldO) or samples of cellular fractions. Prior to the analysis of oxidase activity, total membrane fractions were detergent-solubilized (2% *n*-dodecyl-β-[d]{.smallcaps}-maltoside). Alkaline phosphatase activity was measured spectrophotometrically at 405 nm (Brickman and Beckwith [@CR2]) using Tris-buffered saline (pH 7.4) as assay buffer containing 1.2 μg/μl phosphatase substrate (Sigma; *ɛ* ~405~ = 12.5 mM^−1^ cm^−1^) and 0.02 OD~660~ units of cells (expressing INP-AldO). All activity measurements were performed at ambient temperature, and where appropriate 5 mM MgCl~2~ was included in the assay buffer to stabilize the outer membrane.

Results {#Sec8}
=======

Design of fusion constructs and experimental strategy {#Sec9}
-----------------------------------------------------

Here, we have developed a whole-cell AldO biocatalyst system by directing *S. coelicolor* AldO to the periplasm or cell surface of *E. coli*. For periplasmic transport, we have fused AldO N-terminally to the signal sequences of the endogenous *E. coli* proteins MalE, DsbA, or TorA, known to direct their substrates into the SecB, SRP, or Tat pathway, respectively (Kumamoto and Beckwith [@CR21]; Schierle et al. [@CR33]; Tullman-Ercek et al. [@CR38]). Additionally, we have used a truncated INP variant comprising the InaK N- and C-terminal domain and lacking the central repeating domain for surface display. This INP derivative was fused N-terminally to AldO (Table [1](#Tab1){ref-type="table"}). All fusions are based on a cassette system (Fig. [1](#Fig1){ref-type="fig"}) in which the coding region of *aldo* is cloned *Eco*RI/*Hin*dIII downstream of the indicated export signal, giving rise to Sec-AldO, SRP-AldO, Tat-Aldo, and INP-AldO. Wild-type AldO, lacking a signal sequence, is included in the present study as a negative control. Expression of all constructs is under control of the arabinose-inducible P~BAD~ promotor, allowing moderate overexpression to prevent saturation of export pathways and accompanying cell toxicity. Fig. 1Schematic representation of the hybrid constructs used. All fusions were constructed as described in "[Materials and methods](#Sec2){ref-type="sec"}". For Sec-dependent export, AldO was fused to the signal sequences (*ss*) of MalE or DsbA, resulting in Sec-AldO or SRP-AldO, respectively. For export by the Tat-system, AldO was fused to the signal sequence of TorA, yielding Tat-AldO. AldO was fused to a truncated variant of INP comprising the N- and C-terminal domains for surface display. This construct was termed INP-AldO. Expression of all constructs is driven from an arabinose-inducible P~BAD~ promotor and relevant restriction sites are indicated Table 1Sequences of export signals used in this studySignal peptideSequence^a^MalEMKIKTGARILALSALTTMMFSASALADsbAMKKIWLALAGLVLAFSASAAQTorAMNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQAAINP (InaK~NC~)MTLDKALVLRTCANNMADHCGLIWPASGTVESRYWQSTRRHENGLVGLLWGAGTSAFLSVHADARWIVCEVAVADIISLEEPGMVKFPRAEVVHVGDRISASHFISARQADPASTSTSTSTSTLTPMPTAIPTPMPAVASVTLPVAEQARHEVFDVASVSAAAAPVNTLPVTTPQNLQTATYGSTLSGDNHSRLIAGYGSNETAGNHSDLIGGHDCTLMAGDQSRLTAGKNSVLTAGARSKLIGSEGSTLSAGEDSTLIFRLWDGKRYRQLVARTGENGVEADIPYYVNEDDDIVDKPDEDDDWIEVK^a^The sequence is given in the N- to C-terminal direction

Previous work indicated that AldO expressed in *E. coli* is a soluble protein in agreement with a cytoplasmic localization as predicted by PSORT (Nakai and Horton [@CR30]; Heuts et al. [@CR16]). To unambiguously assess its cellular localization, we first studied the localization of wild-type AldO in *E. coli*. Therefore, cells expressing wild-type AldO were grown to saturation at 17°C, harvested, converted to spheroplasts by EDTA/lysozyme treatment, after which the periplasmic fraction was obtained by osmotic shock. Subsequently, the spheroplasts were disrupted by sonication and subjected to ultracentrifugation to obtain the cytoplasmic fraction. The different subcellular fractions were analyzed by immunoblotting using antisera directed against AldO or riboflavin to study (1) the AldO content of the samples and (2) whether AldO contained covalently bound FAD. Figure [2](#Fig2){ref-type="fig"}a shows that wild-type AldO is cytoplasmically localized and contains covalently bound FAD as previously reported (Heuts et al. [@CR16]). This indicates that AldO is properly folded, as evidenced by the presence of covalent FAD, and functional, as confirmed by the detection of oxidase activity in the cytoplasmic fraction. Fig. 2Subcellular localization of AldO of wild-type AldO (**a**), Sec-AldO (**b**), SRP-AldO (**c**), and Tat-AldO (**d**). *E. coli* cells expressing the indicated constructs were fractionated into total cells (*T*), cytoplasm (*C*), and periplasm (*P*). Samples were normalized on the basis of OD~660~ and analyzed by immunoblotting with the indicated antisera. *Black lines* indicate that intervening lanes have been spliced out. Oxidase activity in the cytoplasmic and periplasmic fraction was determined using xylitol as substrate. *Plus sign*, oxidase activity; *minus sign*, no oxidase activity

As controls to monitor the efficiency of the fractionation procedure, the levels of DnaK and DsbA, which serve as cytoplasmic or periplasmic marker, were analyzed in the same samples by immunoblotting. The data show that DnaK is restricted to the cytoplasmic fraction and DsbA is mainly detected in the periplasmic fraction, demonstrating the efficiency of the fractionation procedure and thereby validating our assay conditions.

Sec-dependent export of AldO to the periplasm {#Sec10}
---------------------------------------------

To examine whether AldO could be functionally transported to the periplasm via the Sec-translocon, AldO was fused to the MalE (Sec-AldO) or DsbA (SRP-AldO) signal sequence.

First, we studied the export of Sec-AldO by cell fractionation and immunoblotting (Fig. [2](#Fig2){ref-type="fig"}b). The results show that Sec-AldO is exported to the periplasm. However, Sec-AldO does not contain covalently bound FAD, unlike purified wild-type AldO, which was included as a positive control (indicated by an arrowhead) in this immunoblot experiment. The absence of FAD indicates that Sec-exported AldO is not folded into its biologically active conformation which was verified by the lack of oxidase activity in the cytoplasmic and periplasmic fraction. Notably, the inability to covalently incorporate FAD destabilizes AldO, resulting in degradation and cytoplasmic aggregation of AldO as indicated by its co-fractionation with other insoluble proteins (data not shown). The efficiency of the fractionation procedure was confirmed by analyzing the DnaK and DsbA levels in the same samples by immunoblotting.

Next, we investigated the periplasmic export of SRP-AldO using the same experimental setup as described above. Figure [2](#Fig2){ref-type="fig"}c shows that SRP-AldO is transported to the periplasm similar to Sec-AldO. Remarkably, a considerable amount of mature-sized AldO is present in the cytoplasmic fraction, which may result from degradation of the DsbA signal sequence by cytoplasmic proteases. This cytoplasmic population of mature-sized AldO contains covalently bound FAD, indicating that it is folded into its active conformation and displays oxidase activity as expected. In contrast, periplasmic AldO does not contain FAD and is not active. Control blots were performed using antisera against DnaK and DsbA, showing that the fractionation protocol is effective.

The results above show that Sec-exported AldO is not active because FAD is not assembled properly into the protein. Apparently, cofactor incorporation is blocked due the inherent requirement of the protein to be unfolded for Sec-dependent export (Driessen and Nouwen [@CR8]).

Tat-dependent export of AldO to the periplasm {#Sec11}
---------------------------------------------

In contrast to the Sec-translocon, the Tat-system is able to transport folded and often cofactor containing proteins to the periplasm (Lee et al. [@CR24]). To test whether this pathway can be used for transport of active AldO to the periplasm, we fused AldO to the Tat signal sequence of TorA (Tat-AldO). The export of Tat-AldO was assayed by cell fractionation and immunoblotting. As shown in Fig. [2](#Fig2){ref-type="fig"}d, a substantial proportion of AldO is clearly exported to the periplasm, whereas a considerable amount of mature-sized AldO is also present in the cytoplasmic fraction, which may result from cytoplasmic degradation of the TorA signal sequence as observed previously with a GFP-TorA signal sequence chimera and similar to SRP-AldO (Fig. [2](#Fig2){ref-type="fig"}c; Thomas et al. [@CR37]). Interestingly, the cytoplasmic and periplasmic populations of mature-sized AldO contain covalently linked FAD, indicating that AldO is folded into its active conformation as confirmed by the detection of oxidase activity in both fractions. The efficiency of the fractionation procedure was verified by analyzing the DnaK and DsbA content in the same samples by immunoblotting.

In conclusion, these data show that AldO can be transported to the periplasm in an active form by the Tat pathway.

Surface display of AldO {#Sec12}
-----------------------

AldO was displayed on the surface of *E. coli* using a truncated INP variant. To examine outer membrane localization of INP-AldO, cells expressing this construct were fractionated into a soluble (cytoplasm and periplasm) and total membrane fraction. The total membrane fraction was further separated into an inner membrane and outer membrane fraction by sarcosyl extraction (Filip et al. [@CR11]). Samples were analyzed by immunoblotting using the indicated antisera. Figure [3](#Fig3){ref-type="fig"}a shows that INP-AldO is detected in the cell extract, soluble fraction, and total membrane fraction. After sarcosyl extraction, INP-AldO is exclusively observed in the outer membrane fraction, suggesting that INP-AldO is indeed localized to the outer membrane. This is in agreement with other recent studies using INP for the surface display of foreign proteins in *E. coli* (Lee et al. [@CR22]; Li et al. [@CR26]; Wu et al. [@CR43]). Moreover, INP-AldO present in these fractions clearly contains covalently bound FAD. This indicates that INP-AldO is properly folded and functional as confirmed by the detection of oxidase activity in the cell extract, soluble fraction, and total membrane fraction. Unfortunately, no oxidase activity could be detected in the inner membrane and outer membrane fractions after sarcosyl extraction, probably due to inactivation of AldO by the detergent used. Fig. 3Subcellular localization of INP-AldO (**a**). *E. coli* cells expressing INP-AldO were fractionated into a cell extract (*CE*), soluble (*S*), and total membrane (*TM*) fraction. The total membrane fraction was further separated into an inner membrane (*IM*) and outer membrane (*OM*) fraction by extraction with 0.5% sarcosyl. Samples were normalized on the basis of OD~660~ and analyzed by immunoblotting with the indicated antisera. Oxidase activity in the cell extract, soluble, and total membrane fraction was determined using xylitol as substrate. *Plus sign*, oxidase activity; *minus sign*, no oxidase activity. **b** Protease accessibility analysis of surface displayed INP-AldO. *E. coli* cells expressing INP-AldO were treated (*plus sign*) or mock-treated (*minus sign*) with proteinase K (*PK*) to degrade cell surface proteins. Samples were normalized on the basis of OD~660~ and analyzed by immunoblotting with the indicated antisera

As controls to verify the efficiency of the fractionation protocol, OmpA and DsbA levels in the same samples were analyzed by immunoblotting. OmpA, which serves as an outer membrane marker, is, as expected, mainly detected in the outer membrane fraction together with INP-AldO. DsbA, which serves as a soluble marker, is exclusively detected in the soluble fraction.

Thus far, the data show that a considerable fraction of FAD-containing INP-AldO is present in outer membrane. However, these data do not confirm whether this protein is indeed surface-localized. To verify surface localization, the accessibility of INP-AldO towards exogenously added proteinase K on whole cells was tested. Samples were analyzed by immunoblotting using the indicated antisera (Fig. [3](#Fig3){ref-type="fig"}b). Clearly, INP-AldO is almost completely degraded after proteinase K treatment when compared to mock-treated cells. To monitor the integrity of the cells, we analyzed the levels of the periplasmic protein DsbA in the same samples which were unaltered by proteinase K treatment. These data confirm that INP-AldO is indeed surface-localized.

Combined, the results show that AldO is successfully displayed at the surface of *E. coli* using a truncated INP variant. Notably, AldO presented at the cell surface contains covalently bound FAD, suggesting that it has attained a correctly folded and active conformation.

Periplasmic localized AldO and surface-displayed AldO as whole-cell biocatalysts {#Sec13}
--------------------------------------------------------------------------------

The export of active AldO to the periplasm or cell surface is of considerable value as it may facilitate the use of these systems in whole-cell biocatalysis. As proof of principle, we therefore assayed spectrophotometrically whether wild-type *E. coli* cells expressing AldO, Tat-AldO, or INP-AldO could be successfully employed in the conversion of xylitol. A representative data set is shown in Fig. [4](#Fig4){ref-type="fig"}. As expected, control cells expressing wild-type AldO did not show significant conversion of xylitol. This suggests that no substantial lysis of the cells has occurred under these conditions. Only upon permeabilization of the cells with toluene was significant conversion of xylitol observed, indicating that cytoplasmic localized, wild-type AldO is unable to react with xylitol probably because xylitol is unable to pass the inner membrane. In the absence of arabinose, no conversion is observed. Interestingly, xylitol is readily converted by cells expressing Tat-AldO. Permeabilization of these cells did not further improve oxidase activity. In contrast, cells expressing INP-AldO only displayed oxidase activity upon permeabilization by toluene, suggesting that the activity and/or substrate accessibility of INP-AldO is compromised in wild-type cells. Fig. 4Conversion of xylitol by *E. coli* cells expressing Tat-AldO or INP-AldO. *E. coli* cells were grown in the absence or presence of arabinose to induce the expression of the indicated constructs; cells were harvested and resuspended in PBS. The conversion of xylitol, using equal amounts of cells, was monitored spectrophotometrically at room temperature. As a negative control, cells expressing wild-type (*wt*) AldO were included. Cells were permeabilized by the addition of 2% toluene, as indicated. The conversion of xylitol is given as the relative whole-cell activity normalized on the basis of OD~660~

From these data, we conclude that export of AldO to the periplasm by the Tat-system is a successful strategy for applying this protein in whole-cell biocatalysis. Cell-surface-displayed AldO, however, showed an unanticipated poor activity with xylitol. It is conceivable that prominent endogenous surface molecules, such as lipopolysaccharides (LPS), inhibit INP-AldO and/or restrict the accessibility of xylitol. To test whether AldO displayed on cells containing truncated LPS molecules is able to convert xylitol successfully, we used the *E. coli waaC* null strain JW3596-1 (Baba et al. [@CR1]). The *waaC* gene product, a heptosyltransferase, plays a pivotal role in the early steps in the synthesis of the inner core region of LPS (Raetz and Whitfield [@CR31]; Frirdich and Whitfield [@CR14]). Consequently, *waaC*-deficient strains express truncated LPS molecules at the cell surface (Raetz and Whitfield [@CR31]; Frirdich and Whitfield [@CR14]). As before, wild-type cells expressing INP-AldO showed significant conversion of xylitol only upon permeabilization by toluene (data not shown). In contrast, JW3596-1 cells expressing INP-AldO displayed oxidase activity irrespective of toluene treatment (data not shown). Reassuringly, wild-type cells and JW3596-1 cells displayed comparable activities of the periplasmic enzyme alkanine phosphatase (data not shown), indicating that the oxidase activity of JW3596-1 cells expressing INP-AldO is not due to leakage of periplasmic enzymes as has been reported for similar strains (Raetz and Whitfield [@CR31]). Taken together, these data are in agreement with the notion that in wild-type cells, the use of cell-surface-displayed AldO in whole-cell biocatalysis is restricted by LPS.

Discussion {#Sec14}
==========

AldO is a recently discovered polyol flavoprotein oxidase that is primarily active with alditols. The enzyme displays exquisite stereoselectivity and is efficient in using molecular oxygen as oxidant (Heuts et al. [@CR16]). These characteristics render AldO a good candidate for further biotechnological exploitation, which is, at present, restricted by costly and laborious purification steps.

In the present study, we have developed an *E. coli*-based whole-cell AldO biocatalyst system, eliminating the need for enzyme purification and enabling the full biotechnological exploitation of AldO. To increase substrate accessibility, which often constitutes a bottleneck in developing whole-cell biocatalyst systems, we directed AldO to the periplasm or cell surface of *E. coli*. For Sec-dependent export to the periplasm, we have fused AldO N-terminally to the endogenous *E. coli* signal sequences of MalE or DsbA. The MalE signal sequence, which directs its substrate into the posttranslational SecB pathway, is commonly used for the periplasmic transport of recombinant proteins (Kumamoto and Beckwith [@CR21]; Mergulhao et al. [@CR29]). Although the DsbA signal sequence is less frequently used for this purpose, several studies have reported its successful application in directing passenger proteins to the periplasm via the co-translational SRP pathway (Schierle et al. [@CR33]; Huber et al. [@CR17]; Marrichi et al. [@CR28]). Additionally, we have fused AldO N-terminally to the signal sequence of TorA for Tat-dependent export to the periplasm. The TorA signal sequence is considered to be highly Tat-specific and is commonly employed for the transport of heterologous proteins to the periplasm (Cristobal et al. [@CR7]; Bruser [@CR3]; Tullman-Ercek et al. [@CR38]). The export of these fusion constructs was examined by cellular fractionation and immunoblotting. The data show that all fusion constructs are directed to the periplasm. However, only Tat-exported AldO was fully active as shown by proper cofactor assembly and oxidase activity in the periplasmic fraction. Similarly, GFP, which is only able to fold in the cytoplasm, was transported to the *E. coli* periplasm when fused to a Sec or Tat signal sequence, but only Tat-exported GFP was active (Feilmeier et al. [@CR10]; Thomas et al. [@CR37]). This result is explained by the export of proteins in a pre-folded, active conformation by the Tat system in contrast to Sec-dependent translocation (Lee et al. [@CR24]). Therefore, our data reinforce the notion that the Tat system is dedicated to the export of pre-folded and often cofactor containing proteins to the periplasm.

Different systems have been described for display of foreign proteins on the cell surface of bacteria. For *E. coli*, these include phage display and systems based on surface anchoring motifs derived of outer membrane proteins, lipoproteins, and auto-transporters (Graether and Jia [@CR15]; Samuelson et al. [@CR32]; Lee et al. [@CR23]; Jose and Meyer [@CR18]). Most of these systems rely on the Sec-translocon for initial transport across the inner membrane. This requires the protein to be unfolded, which interferes with cofactor assembly and activity of AldO as indicated by our data, and therefore, these systems are ruled out for proper export. An alternative system based on an anchoring motif from the ice nucleation protein InaK from *P. syringae* is commonly used for surface display of foreign proteins in *E. coli*, such as viral antigens, single chain antibodies, and enzymes (Jung et al. [@CR19]; Lee et al. [@CR22]; Shimazu et al. [@CR35]; Cho et al. [@CR6]; Kang et al. [@CR20]; Li et al. [@CR26]; Wu et al. [@CR43]; Yim et al. [@CR44]). The structural diversity of these surface-displayed proteins emphasizes the remarkable tolerance and flexibility of the INP system. INP is bound to the cell surface by a GPI anchor and comprises three structurally different domains: a non-repetitive N- and C-terminal domain and a central repetitive domain (Turner et al. [@CR39]; Graether and Jia [@CR15]). The molecular mechanism by which INP facilitates surface display is not clear as no signal sequence could be identified (Schmid et al. [@CR34]). In this respect, it is interesting to note that our data indicate that the export mechanism of INP most likely does not involve the Sec-translocon for translocation across the inner membrane, as surface-displayed INP-AldO contains covalently bound FAD and is functional in contrast to Sec-AldO and SRP-AldO. Different studies suggest that the non-repetitive domains are required for targeting and anchoring to the cell surface (Lee et al. [@CR22]; Shimazu et al. [@CR35], [@CR36]; Wu et al. [@CR43]). However, recent evidence indicates that the N-terminal domain alone is sufficient for cell surface display (Li et al. [@CR26]; Wu et al. [@CR42]). In the present work, we have used a truncated version of INP comprising the InaK N- and C-terminal domains for surface display of AldO in *E. coli*. The cellular localization of this construct was analyzed by cellular fractionation and immunoblotting. The data show that INP-AldO is active as judged by the proper FAD incorporation and oxidase activity in the cell extract, soluble fraction, and total membrane fraction. As expected, INP-Aldo is localized to the outer membrane and is surface-localized as demonstrated by its accessibility towards exogenously added proteinase K.

Compartmentalization of cells is employed by nature to create catalytically efficient environments as exemplified by the periplasmic or extracellular localization of enzymes in *E. coli*, which may be beneficial in cases where, for example, the substrate/product of interest cannot cross the membrane or where the substrate/product is also converted by another intracellular enzyme. Our data illustrate this by showing that wild-type *E. coli* cells expressing Tat-AldO are able to convert xylitol, whereas cells expressing wild-type AldO cannot. Surprisingly, cells expressing surface-displayed INP-AldO are unable to react with xylitol. Conceivably, INP-AldO may be inhibited and/or the accessibility of xylitol may be restricted in wild-type cells by a prominent cell surface molecule, such as LPS. Indeed, surface-displayed AldO on cells of an *E. coli* mutant containing truncated LPS molecules was able to convert xylitol successfully, consistent with the idea that in wild-type cells, LPS restricts the availability of cell surface-displayed AldO for whole-cell biocatalysis.

These data nevertheless demonstrate proof of principle and will further the exploitation of AldO in broad biological and industrial applications. Furthermore, the strategies presented for periplasmic export and surface display are also applicable to other enzymes and, in particular, cofactor-containing enzymes.
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